Detection of caspase-3, neuron specific enolase, and high-sensitivity C-reactive protein levels in both cerebrospinal fluid and serum of patients after aneurysmal subarachnoid hemorrhage

Neurosurgery

Volumn 60, Issue 4, 2007, Pages 674-679

  Kacira, Tibet ^a   Kemerdere, Rahsan ^a   Atukeren, Pinar ^a   Hanimoglu, Hakan ^a   Sanus, Galip Zihni ^a   Kucur, Mine ^a   Tanriverdi, Taner ^a   Gumustas, Koray ^a   Kaynar, Mehmet Yasar ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Aneurysms; Caspase 3; High sensitivity C reactive protein; Neuron specific enolase; Subarachnoid hemorrhage

Indexed keywords

C REACTIVE PROTEIN; CASPASE 3; NEURON SPECIFIC ENOLASE;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BRAIN ARTERY ANEURYSM; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYDROCEPHALUS; MALE; NORMOTENSIVE HYDROCEPHALUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; SUBARACHNOID HEMORRHAGE;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASPASE 3; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOSPHOPYRUVATE HYDRATASE; SUBARACHNOID HEMORRHAGE;

EID: 34147198062     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000255394.77538.BB     Document Type: Article

References (39)

1. Aoki K, Zubkov AY, Ross IB, Zhang JH: Therapeutic effect of caspase inhibitors in the prevention of apoptosis and reversal of chronic cerebral vasospasm. J Clin Neurosci 9:672-677, 2002.
2. Beems T, Simons KS, Van Geel WJ, De Reus HP, Vos PE, Verbeek MM: Serum-and CSF-concentrations of brain specific proteins in hydrocephalus. Acta Neurochir (Wien) 145:37-43, 2003.
3. Berger RP, Pierce MC, Wisniewski SR, Adelson PD, Clark RS, Ruppel RA, Kochanek PM: Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatrics 109:E31, 2002.
4. Bickel C, Rupprecht HJ, Blankenberg S, Espiniola-Klein C, Schlitt A, Rippin G, Hafner G, Treude R, Othman H, Hofmann KP, Meyer J; AtheroGene Investigators: Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 89:901-908, 2002.
5. Butterworth RJ, Wassif WS, Sherwood RA, Gerges A, Poyser KH, Garthwaite J, Peters TJ, Bath PM: Serum neuron-specific enolase, carnosinase, and their ratio in acute stroke. An enzymatic test for predicting outcome? Stroke 27:2064-2068, 1996.
6. Byl B, Deviere J, Saint-Hubert F, Zech F, Gulbis B, Thys JP: Evaluation of tumor necrosis factor-alpha, interleukin-6 and C-reactive protein plasma levels as predictors of bacteremia in patients presenting signs of sepsis without shock. Clin Microbiol Infect 3:306-316, 1997.
7. Dumont AS, Dumont RJ, Chow MM, Lin CL, Calisaneller T, Ley KF, Kassell NF, Lee KS: Cerebral vasospasm after subarachnoid hemorrhage: Putative role of inflammation. Neurosurgery 53:123-135, 2003.
8. Gerdes LU, Jorgensen PE, Nexo E, Wang P: C-reactive protein and bacterial meningitis: A meta-analysis. Scand J Clin Lab Invest 58:383-393, 1998.
9. Handa Y, Kubota T, Kaneko M, Tsuchida A, Kobayashi H, Kawano H, Kubota T: Expression of intercellular adhesion molecule 1 (ICAM-1) on the cerebral artery following subarachnoid hemorrhage in rats. Acta Neurochir (Wien) 132:92-97, 1995.
10. Haraldsen G, Kvale D, Lien B, Farstad IN, Brandtzaeg P: Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells. J Immunol 156:2558-2565, 1996.
11. Hoshi T, Kitagawa K, Yamagami H, Furukado S, Hougaku H, Hori M: Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction. Stroke 36:768-772, 2005.
12. Is M, Coskun A, Sanus GZ, Tanriverdi T, Kafadar AM, Hanimoglu H, Gezen F, Uzan M: High-sensitivity C-reactive protein levels in cerebrospinal fluid and serum of patients with severe head injury: Relationship to tumor necrosis factor-α and IL-6. J Clin Neurosci (in press).
13. Jialal I, Devaraj S: Inflammation and atherosclerosis: The value of the high-sensitivity C-reactive protein assay as a risk marker. Am J Clin Pathol 116 [Suppl]:S108-S115, 2001.
14. Jialal I, Devaraj S, Venugopal SK: C-reactive protein: Risk marker or mediator in atherothrombosis? Hypertension 44:6-11, 2004.
15. Kaynar MY, Tanriverdi T, Kafadar AM, Kacira T, Uzun H, Aydin S, Gumustas K, Dirican A, Kuday C: Detection of soluble intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in both cerebrospinal fluid and serum of patients after aneurysmal subarachnoid hemorrhage. J Neurosurg 101:1030-1036, 2004.
16. Kaynar MY, Tanriverdi T, Kemerdere R, Atukeren P, Gumustas K: Cerebrospinal fluid superoxide dismutase and serum malondialdehyde levels in patients with aneurysmal subarachnoid hemorrhage: Preliminary results. Neurol Res 27:562-567, 2005.
17. Kocer A, Canbulat C, Gozke E, Ilhan A: C-reactive protein is an indicator for fatal outcomes in first-time stroke patients. Med Sci Monit 11:CR540-CR544, 2005.
18. Libby P, Ridker PM: Inflammation and atherosclerosis: Role of C-reactive protein in risk assessment. Am J Med 116 [Suppl 6A]: 9S-16S, 2004.
19. Lima JE, Takayanagui OM, Garcia LV, Leite JP: Use of neuron-specific enolase for assessing the severity and outcome in patients with neurological disorders. Braz J Med Biol Res 37:19-26, 2004.
20. Mabe H, Suzuki S, Mase M, Umemura A, Nagai H: Serum neuron-specific enolase levels after subarachnoid hemorrhage. Surg Neurol 36:170-174, 1991.
21. Macdonald RL, Weir BK: A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 22:971-982, 1991.
22. Matz PG, Fujimura M, Lewen A, Morita-Fujimura Y, Chan PH: Increased cytochrome c-mediated DNA fragmentation and cell death in manganese-superoxide dismutase-deficient mice after exposure to subarachnoid hemolysate. Stroke 32:506-515, 2001.
23. Mayberg MR, Batjer HH, Dacey R, Diringer M, Haley EC, Heros RC, Sternau LL, Torner J, Adams HP Jr, Feinberg W, Thies W: Guidelines for the management of aneurysmal subarachnoid hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 25:2315-2328, 1994.
24. Meguro T, Chen B, Parent AD, Zhang JH: Caspase inhibitors attenuate oxyhemoglobin-induced apoptosis in endothelial cells. Stroke 32:561-566, 2001.
25. Naeimi ZS, Weinhofer A, Sarahrudi K, Heinz T, Vecsei V: Predictive value of S-100B and neuron specific-enolase as marker of traumatic brain damage in clinical use. Brain Inj 20:463-468, 2006.
26. Ogihara K, Zubkov AY, Bernanke DH, Lewis AI, Parent AD, Zhang JH: Oxyhemoglobin-induced apoptosis in cultured endothelial cells. J Neurosurg 91:459-465, 1999.
27. Royds JA, Timperley WR, Taylor CB: Levels of enolase and other enzymes in the cerebrospinal fluid as indices of pathological change. J Neurol Neurosurg Psychiatry 44:1129-1135, 1981.
28. Sonobe M, Suzuki J: Vasospasmogenic substance produced following subarachnoid hemorrhage, and its fate. Acta Neurochir (Wien) 44:97-106, 1978.
29. Tanriverdi T, Sanus GZ, Ulu MO, Tureci E, Uzun H, Aydin S, Kaynar MY: Serum and cerebrospinal fluid concentrations of E-selectin in patients with aneurysmal subarachnoid hemorrhage. Braz J Med Biol Res 38:1703-1710, 2005.
30. Thompson D, Pepys MB, Wood SP: The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure 7:169-177, 1999.
31. Uzun H, Tanriverdi T, Kafadar AM, Sanus GZ, Ertan S, Gumustas K, Kaynar MY: Oxidized low-density lipoprotein and paraoxanase levels in matched serum and cerebrospinal fluid from patients with aneurysmal subarachnoid hemorrhage: Preliminary results. Nepal J Neurosci 2:129-133, 2005.
32. Vainas T, Stassen FR, de Graaf R, Twiss EL, Herngreen SB, Welten RJ, van den Akker LH, van Dieigen-Visser MD, Bruggeman CA, Kitslaar PJ: C-reactive protein in peripheral arterial disease: relation to severity of the disease and to future cardiovascular events. J Vasc Surg 42:243-251, 2005.
33. Vos PE, van Gils M, Beems T, Zimmerman C, Verbeek MM: Increased GFAP and S100beta but not NSE serum levels after subarachnoid haemorrhage are associated with clinical severity. Eur J Neurol 13:632-638, 2006.
34. Wu YC, Zhao YB, Lu CZ, Qiao J, Tan YJ: Correlation between serum level of neuron-specific enolase and long-term functional outcome after acute cerebral infraction: Prospective study. Hong Kong Med J 10:251-254, 2004.
35. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L; INTERHEART Study Investigators: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case- control study. Lancet 364:937-952, 2004.
36. Zubkov AY, Aoki K, Parent AD, Zhang JH: Preliminary study of the effects of caspase inhibitors on vasospasm in dog penetrating arteries. Life Sci 70:3007-3018, 2002.
37. Zubkov AY, Ogihara K, Bernanke DH, Parent AD, Zhang J: Apoptosis of endothelial cells in vessels affected by cerebral vasospasm. Surg Neurol 53:260-266, 2000.
38. Zubkov AY, Tibbs RE, Aoki K, Zhang JH. Morphological changes of cerebral penetrating arteries in a canine double hemorrhage model. Surg Neurol 54:212-220, 2000.
39. Zuccarello M, Kassell NF, Sasaki T, Fujiwara S, Nakagomi T, Lehman RM: Barrier disruption in the major cerebral arteries after experimental subarachnoid hemorrhage in spontaneously hypertensive and normotensive rats. Neurosurgery 21:515-522, 1987.